Munro A, Bewick M, Manuel L, Cameron J S, Ellis F G, Boulton-Jones M, Ogg C S
Br Med J. 1971 Jul 31;3(5769):271-6. doi: 10.1136/bmj.3.5769.271.
The formation of spontaneous rosettes by peripheral blood or spleen mononuclear cells when incubated with sheep red blood cells has proved a useful way of assessing the potency of immunosuppressive drugs and antilymphocyte sera in vitro. A test employing the inhibition by antilymphocyte globulin (A.L.G.) of spontaneous rosette formation around peripheral blood mononuclear cells is described. This has been used to assess the degree of immunosuppression in patients with renal allografts and uraemic patients on regular haemodialysis.Twenty-three patients with renal allografts had 21 clinically diagnosed episodes of rejection. In none of these rejection episodes was the minimal inhibitory concentration (M.I.C.) of A.L.G. (that necessary to reduce the spontaneous rosette formation of peripheral cells by 75%) less than 1/50,000. Nineteen patients had no rejection episodes during 57 patient/months of continuous observation while the M.I.C. was at a greater dilution than 1/50,000. The test has therefore been of great value in suggesting when an individual is capable of rejecting his graft, and allows the dose of immunosuppressive drugs to be adjusted to a minimum in a controlled fashion. It has been of use in diagnosing rejection in the anuric patient, when the distinction between rejection, urinary tract obstruction, and infection is particularly difficult.Fifteen patients maintained on regular haemodialysis for more than a year had, as judged by this technique, less reactive lymphocytes than normal healthy controls. The degree of immunosuppression was not as great as in the patients on full immunosuppressive regimens.
外周血或脾单核细胞与绵羊红细胞一起孵育时形成自发玫瑰花结,已被证明是在体外评估免疫抑制药物和抗淋巴细胞血清效力的一种有用方法。本文描述了一种利用抗淋巴细胞球蛋白(A.L.G.)抑制外周血单核细胞周围自发玫瑰花结形成的试验。该试验已用于评估肾移植患者和定期血液透析的尿毒症患者的免疫抑制程度。23例肾移植患者发生了21次临床诊断的排斥反应。在这些排斥反应中,A.L.G.的最小抑制浓度(M.I.C.)(即使外周细胞自发玫瑰花结形成减少75%所需的浓度)均不低于1/50,000。19例患者在57个患者/月的连续观察期间未发生排斥反应,此时M.I.C.的稀释度大于1/50,000。因此,该试验在提示个体是否有能力排斥其移植物方面具有重要价值,并能以可控方式将免疫抑制药物的剂量调整至最低。该试验在诊断无尿患者的排斥反应时也很有用,此时区分排斥反应、尿路梗阻和感染特别困难。通过该技术判断,15例维持定期血液透析一年以上的患者,其淋巴细胞反应性低于正常健康对照。免疫抑制程度不如接受完全免疫抑制方案的患者严重。